Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
William J. Elliott & Evgeny A. Bistrika. (2018) Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation. Expert Opinion on Drug Safety 17:2, pages 207-216.
Read now
Read now
Lorenzo Ghiadoni. (2011) Perindopril for the treatment of hypertension. Expert Opinion on Pharmacotherapy 12:10, pages 1633-1642.
Read now
Read now
Jasper J Brugts, Roberto Ferrari & Maarten L Simoons. (2009) Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease. Expert Review of Cardiovascular Therapy 7:4, pages 345-360.
Read now
Read now
Roberto Ferrari. (2008) Optimizing the treatment of hypertension and stable coronary artery disease: clinical evidence for fixed-combination perindopril/amlodipine. Current Medical Research and Opinion 24:12, pages 3543-3557.
Read now
Read now
Articles from other publishers (32)
Huitao Gao, Hongzhong Liu, Xin Zheng, Xinge Cui, Stephanie Bricout-Hennel, Arnaud Lucien, Pauline Lauruol, Yaqin Wang, Xue Wang, Hongyun Wang & Chen Rui. (2023) Potential pharmacokinetic interactions in fixed-dose combinations of perindopril/indapamide/amlodipine compared with perindopril/indapamide and amlodipine in healthy Chinese volunteers. Acta Materia Medica 2:1.
Crossref
Crossref
Asmaa M. Abdel Rahim & Esraa M.M. Mahmoud. (2022) A Novel Magnetic Polyethylene Glycol Nanocomposite based on Graphite Reinforcement Carbon Paste Electrode for Voltammetric Determination of Perindopril L-arginine. Journal of Analytical Chemistry 77:7, pages 914-925.
Crossref
Crossref
Marta Kus, Klaudia Gorniak, Piotr Czaklosz, Anna Olejnik, Paulina Skupin-Mrugalska, Izabela Ibragimow & Hanna Piotrowska-Kempisty. (2022) Permeability of the Perindopril Arginine under In Vitro Conditions across Caco-2 Monolayer and Biomimetic Phospholipid Membrane. Molecules 27:7, pages 2232.
Crossref
Crossref
Joanna Bojarska, Milan Remko, Martin Breza, Izabela Madura, Andrzej Fruziński & Wojciech M. Wolf. (2020) A Proline-Based Tectons and Supramolecular Synthons for Drug Design 2.0: A Case Study of ACEI. Pharmaceuticals 13:11, pages 338.
Crossref
Crossref
John S. Sampalis, Eliofotisti Psaradellis, Melissa Stutz, Jenaya Rickard & Emmanouil Rampakakis. (2018) Post Hoc Analysis of the CONFIDENCE II, PROTECT I, SHAKE THE HABIT I and SHAKE THE HABIT II Observational Studies in Mild to Moderate Hypertensive Patients Treated with Perindopril and Atorvastatin Concomitantly. Drugs in R&D 18:4, pages 283-293.
Crossref
Crossref
Teja Prijatelj, Mateja Grošelj & Breda Barbič-Žagar. (2018) Blood Pressure Control for Health Benefits in all Grades of Hypertension. Cardiologia Croatica 13:9-10, pages 251-255.
Crossref
Crossref
N. N. Nikulina. (2018) The effectiveness of the replacement of the generic blockers of the renin-angiotensin-aldosterone system by perindopril arginine in patients with uncontrolled blood pressure: the results of the regional program “DIFFERENCE”. "Arterial’naya Gipertenziya" ("Arterial Hypertension") 24:3, pages 359-368.
Crossref
Crossref
Nadavala Siva Kumar, Vudagandla Sreenivasulu, Bondigalla Ramachandra, Mohammad Asif & Ahmed A. Ibrahim. (2018) A Stability-Indicating LC-MS Method for Determination of Perindopril and its Process Related Impurities. Pharmaceutical Chemistry Journal 52:4, pages 378-383.
Crossref
Crossref
Lukasz P. Bialy, Cezary Wojcik & Izabela Mlynarczuk-Bialy. (2018) Mucosal delivery systems of antihypertensive drugs: A practical approach in general practice. Biomedical Papers 162:2, pages 71-78.
Crossref
Crossref
A. A Spasov & V. A Kosolapov. (2018) DRUG DEVELOPMENT BASED ON PHARMACEUTICAL ALTERNATIVES. Journal of Volgograd State Medical University 15:3, pages 3-7.
Crossref
Crossref
Katarina Hatalova, Daniel Pella, Rastislav Sidlo & Robert Hatala. (2016) Switching from a Free Association of Perindopril/Amlodipine to a Fixed-Dose Combination: Increased Antihypertensive Efficacy and Tolerability. Clinical Drug Investigation 36:7, pages 591-598.
Crossref
Crossref
Dayi Hu, Yihong Sun, Yuhua Liao, Jing Huang, Ruiping Zhao & Kan Yang. (2016) Efficacy and Safety of Fixed-Dose Perindopril Arginine/Amlodipine in Hypertensive Patients Not Adequately Controlled with Amlodipine 5 mg or Perindopril <b><i>tert</i></b>-Butylamine 4 mg Monotherapy. Cardiology 134:1, pages 1-10.
Crossref
Crossref
Ahmed S. Saad, Nisreen F. Abo-Talib & Mohamed R. El-Ghobashy. (2016) Novel ratio difference at coabsorptive point spectrophotometric method for determination of components with wide variation in their absorptivities. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 152, pages 480-484.
Crossref
Crossref
Matt Shirley & Paul L. McCormack. (2015) Perindopril/Amlodipine (Prestalia®): A Review in Hypertension. American Journal of Cardiovascular Drugs 15:5, pages 363-370.
Crossref
Crossref
Zoltán-István Szabó, Zenkő-Zsuzsánna Réti, László Gagyi, Erika Lilla Kis & Emese Sipos. (2015) Simultaneous Quantification of Related Substances of Perindopril Tert-Butylamine Using a Novel Stability Indicating Liquid Chromatographic Method. Journal of Chromatographic Science 53:3, pages 424-430.
Crossref
Crossref
Krzysztof Łukawski, Grzegorz Raszewski & Stanisław J. Czuczwar. (2014) Interactions between levetiracetam and cardiovascular drugs against electroconvulsions in mice. Pharmacological Reports 66:6, pages 1100-1105.
Crossref
Crossref
Magdalena Paczkowska, Przemysław Zalewski, Piotr Garbacki, Alicja Talaczyńska, Anna Krause & Judyta Cielecka-Piontek. (2014) The Development and Validation of a Stability-Indicating UHPLC-DAD Method for Determination of Perindopril l-Arginine in Bulk Substance and Pharmaceutical Dosage Form. Chromatographia 77:21-22, pages 1497-1501.
Crossref
Crossref
D I Trukhan & L V Tarasova. (2014) Optimization of drug therapy of coronary heart disease and arterial hypertension: choice angiotensin-converting enzyme inhibitors. Systemic Hypertension 11:1, pages 73-77.
Crossref
Crossref
Elien Van Bever, Veronika J. Wirtz, Majda Azermai, Geert De Loof, Thierry Christiaens, Luc Nicolas, Luc Van Bortel & Robert Vander Stichele. (2014) Operational rules for the implementation of INN prescribing. International Journal of Medical Informatics 83:1, pages 47-56.
Crossref
Crossref
H. E. Zaazaa, S. S. Abbas, H. A. M. Essam & M. G. El-Bardicy. (2012) Validated Chromatographic Methods for Determination of Perindopril and Amlodipine in Pharmaceutical Formulation in the Presence of their Degradation Products. Journal of Chromatographic Science 51:6, pages 533-543.
Crossref
Crossref
M. Remko, J. Bojarska, P. Ježko, W. Maniukiewicz & A. Olczak. (2013) Molecular structure of antihypertensive drug perindopril, its active metabolite perindoprilat and impurity F. Journal of Molecular Structure 1036, pages 292-297.
Crossref
Crossref
Joanna Bojarska, Waldemar Maniukiewicz, Lesław Sieroń, Piotr Kopczacki, Krzysztof Walczyński & Milan Remko. (2012) Perindoprilat monohydrate. Acta Crystallographica Section C Crystal Structure Communications 68:11, pages o443-o446.
Crossref
Crossref
Jagdishwar R. Patel, Robert A. Carlton, Fnu Yuniatine, Thomas E. Needham, Lianming Wu & Frederick G. Vogt. (2012) Preparation and Structural Characterization of Amorphous Spray-Dried Dispersions of Tenoxicam with Enhanced Dissolution. Journal of Pharmaceutical Sciences 101:2, pages 641-663.
Crossref
Crossref
Vânia André, Luís Cunha-Silva, M. Teresa Duarte & Pedro Paulo Santos. (2011) First Crystal Structures of the Antihypertensive Drug Perindopril Erbumine: A Novel Hydrated Form and Polymorphs α and β. Crystal Growth & Design 11:9, pages 3703-3706.
Crossref
Crossref
M. Remko, J. Bojarska, P. Ježko, L. Sieroń, A. Olczak & W. Maniukiewicz. (2011) Crystal and molecular structure of perindopril erbumine salt. Journal of Molecular Structure 997:1-3, pages 103-109.
Crossref
Crossref
George Tsoukas, Sanjiv Anand & Kwang Yang. (2011) Dose-Dependent Antihypertensive Efficacy and Tolerability of Perindopril in a Large, Observational, 12-Week, General Practice-Based Study. American Journal Cardiovascular Drugs 11:1, pages 45-55.
Crossref
Crossref
F. Lagrange. (2010) Déconditionnement et stabilité des formes orales sèches solides : états des connaissances. Annales Pharmaceutiques Françaises 68:6, pages 332-358.
Crossref
Crossref
Dan-Dominic Ionescu. (2009) Antihypertensive Efficacy of Perindopril 5–10 mg/day in Primary Health Care. Clinical Drug Investigation 29:12, pages 767-776.
Crossref
Crossref
Сергей Владимирович Недогода & S V Nedogoda. (2009) Perindopril in treatment of patients with arterial hypertension and high cardiovascular risk. Systemic Hypertension 6:2, pages 10-15.
Crossref
Crossref
Milan Remko. (2009) Molecular structure and stability of perindopril erbumine and perindopril l-arginine complexes. European Journal of Medicinal Chemistry 44:1, pages 101-108.
Crossref
Crossref
Ahmed ZaiemFaiez Zannad. (2008) Perindopril: beyond lowering blood pressure. Future Cardiology 4:3, pages 219-235.
Crossref
Crossref
Kim Fox. (2007) Contribution of perindopril to cardiology: 20 years of success. European Heart Journal Supplements 9:suppl_E, pages E10-E19.
Crossref
Crossref